27 Ottobre 2023

webinar

President: Paolo Marchetti, Daniele Santini

In the last years the HER 2 positive disease has undergone a real revolution. The landscape has been radically changed with the advent of new therapeutic strategy. If on one side this represents a great opportunity for cancer patients, on the other hand detect the comparison with novel toxicity profiles. The knowledge of the biological mechanisms underlying of this tumour type plays a crucial role to identify the best therapeutic path for cancer patients.In this course, opinion leaders of undisputed prestige provide a moment of scientific development and constructive dialogue able to ensure an event of high impact.

Segreteria Scientifica: Andrea Botticelli Agnese Fabbri, Giuliana D’Auria, Simone Scagnoli, Simona Pisegna

Crediti Formativi: A questo evento sono stati attribuiti n. 3 crediti ECM Provider ECM n. 3 – Rif. Evento n. 391851

Obiettivo formativo: Documentazione clinica, percorsi clinico-assistenziali diagnostici e riabilitativi, profili di assistenza, profili di cura

Professione: Medico Chirurgo

Discipline: Dermatologia e Venerologia, Oncologia, Chirurgia Generale,Ginecologia e Ostetricia

Provider: Didactika S.r.l. – Piazza della Trasfigurazione, 8/a – 00151 Roma Tel. e fax: 06 94378432 – Email: info@didactika.it

programma